Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS
Status:
NOT_YET_RECRUITING
Trial end date:
2029-12-02
Target enrollment:
Participant gender:
Summary
To learn about the safety and effects of M032 given directly into the tumor in children and adults with DMG and who have received standard-of-care radiation therapy.